Chandler-Laney chosen as Named New Investigator for NORC
Paula Chandler-Laney, Ph.D. has been selected as this year’s Named New Investigator for the UAB Nutrition Obesity Research Center (NORC). The center leadership selects among the funded pilot/feasibility recipients and then receives approval from National Institute of Diabetes and Digestive and Kidney Diseases program, which funds NORC’s grant.Chandler-Laney is an assistant professor in the Department of Nutrition Sciences. She joined the faculty in 2011 after transferring from a postdoctoral fellow. Her research program is focused on understanding pre- and early post-natal behavioral and metabolic predictors of childhood obesity.
The pilot project Chandler-Laney will work on in the next year is entitled “The use of a jaw motion sensor to objectively measure infant feeding behavior.” The study aims to examine the validity of the jaw motion sensor to estimate meal duration, sucking burst duration, sucking rate, and volume of intake among breast-fed and formula-fed infants.
“If successful, this pilot study will complement and enhance my research program by providing a novel and non-invasive measure of infant feeding behavior and energy intake,” said Chandler-Laney.
The first person to hold the new investigator distinction was Barbara Gower, Ph.D., who happens to be Chandler-Laney’s mentor.
UAB Department of Nutrition Sciences Clinical Trials Support New Weight Loss Drug Approved By FDA
The U.S. Food and Drug Administration late Tuesday approved a new diet drug tested in several clinical trials at UAB.Dr. Tim Garvey, a UAB endocrinologist and the Chair of the Department of Nutrition Sciences, said the drug Qsymia will be an important new weapon in the fight to reduce American obesity and an epidemic of type 2 diabetes. Dr. Garvey was the primary investigator at UAB for a phase 2 and several phase 3 trials of Qsymia.
More information about the new drug Qsymia and quotes from Dr. Garvey can be found through the following links:
TIME.com
